» Authors » A Helena Jonsson

A Helena Jonsson

Explore the profile of A Helena Jonsson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 2094
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Donado C, Theisen E, Zhang F, Nathan A, Fairfield M, Rupani K, et al.
Nature . 2025 Feb; PMID: 39914456
Granzymes are a family of serine proteases mainly expressed by CD8 T cells, natural killer cells, and innate-like lymphocytes. Although their primary function is thought to be the induction of...
2.
Oakes E, Dillon E, Buhler K, Guan H, Paudel M, Marks K, et al.
J Autoimmun . 2024 Aug; 148:103299. PMID: 39096716
Objective: Autoantibodies and autoimmune diseases after SARS-CoV-2 infection are widely reported. Given evolving variants, milder infections, and increasing population vaccination, we hypothesized that SARS-CoV-2 infection earlier in the pandemic would...
3.
Law C, Wacleche V, Cao Y, Pillai A, Sowerby J, Hancock B, et al.
Nature . 2024 Jul; 632(8025):E6. PMID: 39060417
No abstract available.
4.
Law C, Wacleche V, Cao Y, Pillai A, Sowerby J, Hancock B, et al.
Nature . 2024 Jul; 631(8022):857-866. PMID: 38987586
Systemic lupus erythematosus (SLE) is prototypical autoimmune disease driven by pathological T cell-B cell interactions. Expansion of T follicular helper (T) and T peripheral helper (T) cells, two T cell...
5.
Donado C, Jonsson A, Theisen E, Zhang F, Nathan A, Rupani K, et al.
bioRxiv . 2024 Jun; PMID: 38826230
Granzymes are a family of serine proteases mainly expressed by CD8 T cells, natural killer cells, and innate-like lymphocytes. Although their major role is thought to be the induction of...
6.
Kawano Y, Wang X, Patel N, Qian G, Kowalski E, Bade K, et al.
J Rheumatol . 2023 Oct; 51(3):305-312. PMID: 37839812
Objective: To determine the incidence and baseline factors associated with breakthrough coronavirus disease 2019 (COVID-19) after preexposure prophylaxis (PrEP) with tixagevimab/cilgavimab among patients with systemic autoimmune rheumatic diseases (SARDs). Methods:...
7.
Wang R, Singaraju A, Marks K, Shakib L, Dunlap G, Adejoorin I, et al.
Sci Immunol . 2023 Jul; 8(85):eadd1591. PMID: 37506196
Immune checkpoint inhibitor (ICI) therapies used to treat cancer, such as anti-PD-1 antibodies, can induce autoimmune conditions in some individuals. The T cell mechanisms mediating such iatrogenic autoimmunity and their...
8.
Tedeschi S, Solomon D, Rao D, Jonsson A, Wesemann D
Semin Arthritis Rheum . 2023 May; 61:152223. PMID: 37210284
No abstract available.
9.
Dunlap G, Wagner A, Meednu N, Zhang F, Jonsson A, Wei K, et al.
bioRxiv . 2023 Mar; PMID: 36993527
Rheumatoid arthritis (RA) is an autoimmune disease initiated by antigen-specific T cells and B cells, which promote synovial inflammation through a complex set of interactions with innate immune and stromal...
10.
Tedeschi S, Solomon D, Chen Y, Ellrodt J, Whelan M, Stratton J, et al.
Semin Arthritis Rheum . 2023 Feb; 59:152177. PMID: 36796211
Objective: Disease-modifying anti-rheumatic drugs (DMARDs) that treat rheumatoid arthritis (RA) may reduce immune responses to COVID-19 vaccination. We compared humoral and cell-mediated immunity before and after a 3rd dose of...